Analysis of autophagy-related gene signature associated with clinical prognosis and immune microenvironment in colorectal cancer

Author:

Miao Dazhuang1,Song Yushuai1,Liang Guanying1,Wang Yan1,He Wei2,Huang Luyu1,Lu Hongnan1,Jiang Shixiong1,Jia Yunhe1,Li Zhiwei1,Tong Jinxue1

Affiliation:

1. Harbin Medical University Cancer Hospital

2. Zigong Third People's Hospital

Abstract

Abstract Purpose: Autophagy has a critical involvement in the initiation and progression of various cancers, including colorectal cancer (CRC). The feasibility of using autophagy-related genes as prognostic tools for CRC patients is yet to be determined. Methods: We gathered RNA sequencing data and clinical details for colorectal cancer (CRC) from TCGA as our training set and used the GSE39582 dataset from the GEO database for validation. Autophagy-related genes (ARGs) were obtained from the Human Autophagy Database. Using the R limma package, we identified differentially expressed ARGs (DAGs) in TCGA's CRC samples. Prognostic DAGs signatures were established via Cox and LASSO Cox regression analyses. CRC patients were divided into high-risk and low-risk groups based on median risk scores, with their prognosis assessed through Kaplan-Meier, ROC, and calibration curve analyses. The CIBERSORT algorithms were employed to examine the association between immune status and the signature. Immunohistochemistry assays were conducted to evaluate the prognostic significance of these DAGs in CRC samples. Results: Our study developed a signature consisting of 11 key prognostic DAGs (CANX, NRG1, WIPI1, EIF2AK3, WDR45, PELP1, ULK1, WIPI2, DAPK1, ULK3, MAP1LC3C), revealing that high-risk patients had markedly reduced overall survival compared to low-risk ones. This signature, independently predictive after adjusting for clinical factors, was validated using the GSE39582 dataset and showed a strong correlation with immune status in TCGA CRC samples. Conclusion: The autophagy-related signature independently predicts CRC prognosis and guides immunotherapy strategies.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3